Balanced news tone
News Sentiment
MRK sentiment intelligence
Merck & Company Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
49 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-3.5% over one week, -6.1% over four weeks, trend active, and near fair-value range.
Merck Expands TL1A Lead With Positive Tulisokibart Results In UC
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
-3.5%
Price reacting lower
Trend fit
Trend active
-6.1% over four weeks
Fair value
13.8%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
17
Neutral
28
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Merck & Co. stock (US58933Y1055): What investors are watching now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- AD HOC NEWS
Seeking Alpha
Direct company coverage
Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise (NYSE:MRK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Seeking Alpha
The Motley Fool
Direct company coverage
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- The Motley Fool
AD HOC NEWS
Direct company coverage
Merck & Co., Inc. stock (US58933Y1055): shares steady on NYSE as investors digest recent news flow
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- AD HOC NEWS
TIKR.com
Direct company coverage
Merck Stock After a 60% Rally From Its Lows: Is It Still Worth Buying at $120?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- TIKR.com
Trefis
Direct company coverage
Five-Year Tally: Merck Stock Delivers $47 Bil Gain
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Trefis
AD HOC NEWS
Direct company coverage
Merck & Co. stock (US58933Y1055): A major patent update and product pipeline remain in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- AD HOC NEWS
Investor's Business Daily
Direct company coverage
Merck Stock Zooms Closer To A Breakout On 'A New Chapter' In Cancer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Investor's Business Daily
Business Wire
Direct company coverage
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 May 2026 07:00
- Source
- Business Wire
TradingView
Direct company coverage
Merck Rises 11% YTD: Should Investors Buy, Sell or Hold the Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Why Merck (MRK) Shares Are Trading Lower Today
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Declines While Market Improves: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Merck CFO and R&D chief join TD Cowen health care fireside chat
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Stock Titan
Capital.com
Direct company coverage
Merck & Company Stock Forecast 2026–2030 | Future Outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 18 Feb 2026 08:00
- Source
- Capital.com
AskTraders
Direct company coverage
Merck Stock (MRK) Hitting Highs Into Earnings – Eyes On Breakout
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Feb 2026 08:00
- Source
- AskTraders
Business Wire
Direct company coverage
Merck to Complete Acquisition of Cidara Therapeutics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jan 2026 08:00
- Source
- Business Wire
24/7 Wall St.
Direct company coverage
Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Dec 2025 08:00
- Source
- 24/7 Wall St.
XTB.com
Direct company coverage
Stock of the Week - Merck & Co Inc (23.10.2025)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Oct 2025 07:00
- Source
- XTB.com